medicare semaglutide is expanding access to weight-loss GLP-1 medications. Starting July 1, eligible Medicare beneficiaries can receive GLP-1 prescriptions for obesity for $50 a month through a new federal pilot program, even without Medicare Coverage of Novo's Semaglutide

NICE guidelines recommend achieving an HbA1c level below 48 mmol/mol (6.5%) before discontinuing contraception, provided this can be accomplished without problematic hypoglycaemia

IV therapy can be beneficial for providing immediate energy or hydration, while promoting vitality and serving as preventative care

Active GLP-1 secretion is significantly greater with unsaturated fatty acids such as oleic, linoleic and linolenic acids than with palmitic acid

OvertonHABabbsAJDoelSMFyfeMCGardnerLSGriffinGet al

By inhibiting glucagon production, GLP-1 receptor agonists help maintain lower blood glucose levels, preventing unwanted spikes